Monitoring Crohn’s disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard
- 3 October 2015
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 26 (7) , 2107-2117
Abstract
To assess the ability of magnetic resonance enterography global score (MEGS) to characterise Crohn’s disease (CD) response to anti-TNF-α therapy. Thirty-six CD patients (median age 26 years, 20 males) commencing anti-TNF-α therapy with concomitant baseline MRI enterography (MRE) were identified retrospectively. Patients’ clinical course was followed and correlated with subsequent MREs. Scan order was randomised and MEGS (a global activity score) was applied by two blinded radiologists. A physician’s global assessment of the disease activity (remission, mild, moderate or severe) at the time of MRE was assigned. The cohort was divided into clinical responders and non-responders and MEGS compared according to activity status and treatment response. Interobserver agreement was assessed. Median MEGS decreased significantly between baseline and first follow-up in responders (28 versus 6, P < 0.001) but was unchanged in non-responders (26 versus 18, P = 0.28). The median MEGS was significantly lower in clinical remission (9) than in moderate (14) or severe (29) activity (P < 0.001). MEGS correlated significantly with clinical activity (r = 0.53; P < 0.001). Interobserver Bland-Altman limits of agreement (BA LoA) were -19.7 to 18.5. MEGS decreases significantly in clinical responders to anti-TNF-α therapy but not in non-responders, demonstrates good interobserver agreement and moderate correlation with clinical disease activity. • MRI scores of Crohn’s activity are used increasingly in clinical practice and therapeutic trials. • Such scores have been advocated as biomarkers of therapeutic response. • MEGS reflects clinical response to anti-TNF-α therapy and the clinical classification of disease activity. • MEGS demonstrates good interobserver agreement.Keywords
This publication has 28 references indexed in Scilit:
- Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of ActivityAmerican Journal of Gastroenterology, 2014
- Grading Crohn Disease Activity With MRI: Interobserver Variability of MRI Features, MRI Scoring of Severity, and Correlation With Crohn Disease Endoscopic Index of SeverityAmerican Journal of Roentgenology, 2013
- Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectinEuropean Radiology, 2013
- Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelinesJournal of Crohn's and Colitis, 2013
- Serial Magnetic Resonance Imaging for Monitoring Medical Therapy Effects in Crohn’s DiseaseInflammatory Bowel Diseases, 2013
- Mucosal Healing in Crohnʼs DiseaseInflammatory Bowel Diseases, 2013
- Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity indexEuropean Journal of Radiology, 2012
- Diagnostic and therapeutic impact of MR enterography in Crohn’s diseaseClinical Radiology, 2011
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialThe Lancet, 2008
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006